ASHLEY UTTERMANN: Open Payments
NPI 1588397921 · BRANFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 38 payments from 14 companies in 2025. Trend: 2023 $800 · 2024 $840 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $230 |
| Lilly USA, LLC | 6 | $164 |
| Novo Nordisk Inc | 3 | $93 |
| PFIZER INC. | 3 | $71 |
| Amneal Pharmaceuticals LLC | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Exact Sciences Corporation | 2 | $41 |
| Almatica Pharma LLC | 2 | $39 |
| Amgen Inc. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $34 |
Products named: AIRSUPRA, BREZTRI, MOUNJARO, Wegovy, UNITHROID, PAXLOVID, Cologuard Collection Kit, LOREEV XR.
Industry payments across CT — which companies pay providers there.
